Donenberg Phillip B.
- SEC CIK
- 0001238120
No open-market purchases or sales filed in the past year.
Current role at each company
- FTH Faeth Therapeutics, Inc.Directoras of Jun 12, 2026
- TECX Tectonic Therapeutic, Inc.Directoras of Jun 10, 2026
- TSHA Taysha Gene Therapies, Inc.Directoras of Jun 2, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Donenberg Phillip B. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
TSHA Taysha Gene Therapies, Inc.
Director2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 16, 2023 (view filing) | Aug 16 | Same day | Donenberg Phillip B.Director | PPurchase | +111.1K | $0.90 | +$100.0K | +3,703.7%114.1K after | |
| Feb 3, 2022 (view filing) | Feb 2 | 1 day | Donenberg Phillip B.Director | PPurchase | +3.00K | $7.78 | +$23.3K | New position3.00K after |